Alyeska Investment Group, L.P. Sutro Biopharma, Inc. Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	BUY	$8.8 - $11.87 $1,328 - $1,792	151 Added 0.3%	50,151 $0
Q4 2018 Feb 14, 2019	SELL	$8.69 - $14.85 $434,500 - $742,500	-50,000 Reduced 50.0%	50,000 $451,000
Q3 2018 Nov 14, 2018	BUY	$15.0 - $15.2 $1.5 Million - $1.52 Million	100,000 New	100,000 $1.5 Million

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $139M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.